Details for New Drug Application (NDA): 216912
✉ Email this page to a colleague
The generic ingredient in BORTEZOMIB is bortezomib. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the bortezomib profile page.
Summary for 216912
Tradename: | BORTEZOMIB |
Applicant: | Scinopharm Taiwan |
Ingredient: | bortezomib |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 216912
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Strength | 3.5MG/VIAL | ||||
Approval Date: | Sep 26, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription